Matches in SemOpenAlex for { <https://semopenalex.org/work/W94748627> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W94748627 endingPage "32" @default.
- W94748627 startingPage "2919" @default.
- W94748627 abstract "The topoisomerase inhibitors, camptothecin and etoposide target the activity of topoisomerase I and II respectively. These agents, or their analogues, are undergoing clinical trials for the treatment of metastatic breast cancer. In this study, we examined the response of eight breast epithelial cell lines, including six lines derived from breast cancers and two immortalized normal epithelial lines to camptothecin and etoposide. The lines varied by 700 fold in their sensitivity to the growth inhibiting effects of camptothecin and 30 fold in their response to etoposide. The BT474 line was the most resistant to both agents. The other cell lines did not have uniform sensitivity to both drugs, i.e., some lines were sensitive to one drug but relatively resistant to the other. A variety of parameters in these lines were analyzed to elucidate mechanisms of resistance including S phase, doubling time, expression and activity of topoisomerase I and II, expression of mdr-1, p53 status, cell cycle arrest, level of apoptosis, and expression of the apoptotic proteins Bcl-2 and Bax. We found that low levels of the topo I protein and its enzymatic activity were associated with increased resistance to camptothecin. This was not true for topo II activity and etoposide. Increased apoptotic responses were generally observed in cell lines that were sensitive to etoposide and this correlated with low ratios of Bcl-2/Bax protein. No single parameter was entirely predictive of response. However, the BT474 line displayed a series of characteristics including slow growth, the presence of mutant p53, low topo I activity, and a high Bcl-2/Bax ratio which together likely contributed to the resistance of this line to both etoposide and camptothecin." @default.
- W94748627 created "2016-06-24" @default.
- W94748627 creator A5024552432 @default.
- W94748627 creator A5032566475 @default.
- W94748627 creator A5038095090 @default.
- W94748627 creator A5039374612 @default.
- W94748627 creator A5063384149 @default.
- W94748627 creator A5068672834 @default.
- W94748627 date "1998-08-26" @default.
- W94748627 modified "2023-10-17" @default.
- W94748627 title "Complex response of breast epithelial cell lines to topoisomerase inhibitors." @default.
- W94748627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9713486" @default.
- W94748627 hasPublicationYear "1998" @default.
- W94748627 type Work @default.
- W94748627 sameAs 94748627 @default.
- W94748627 citedByCount "12" @default.
- W94748627 countsByYear W947486272013 @default.
- W94748627 countsByYear W947486272014 @default.
- W94748627 countsByYear W947486272015 @default.
- W94748627 crossrefType "journal-article" @default.
- W94748627 hasAuthorship W94748627A5024552432 @default.
- W94748627 hasAuthorship W94748627A5032566475 @default.
- W94748627 hasAuthorship W94748627A5038095090 @default.
- W94748627 hasAuthorship W94748627A5039374612 @default.
- W94748627 hasAuthorship W94748627A5063384149 @default.
- W94748627 hasAuthorship W94748627A5068672834 @default.
- W94748627 hasConcept C147897179 @default.
- W94748627 hasConcept C190283241 @default.
- W94748627 hasConcept C202751555 @default.
- W94748627 hasConcept C2776694085 @default.
- W94748627 hasConcept C2778119113 @default.
- W94748627 hasConcept C2778616834 @default.
- W94748627 hasConcept C2779682216 @default.
- W94748627 hasConcept C2779707156 @default.
- W94748627 hasConcept C29537977 @default.
- W94748627 hasConcept C502942594 @default.
- W94748627 hasConcept C54355233 @default.
- W94748627 hasConcept C55493867 @default.
- W94748627 hasConcept C81885089 @default.
- W94748627 hasConcept C86803240 @default.
- W94748627 hasConcept C98274493 @default.
- W94748627 hasConceptScore W94748627C147897179 @default.
- W94748627 hasConceptScore W94748627C190283241 @default.
- W94748627 hasConceptScore W94748627C202751555 @default.
- W94748627 hasConceptScore W94748627C2776694085 @default.
- W94748627 hasConceptScore W94748627C2778119113 @default.
- W94748627 hasConceptScore W94748627C2778616834 @default.
- W94748627 hasConceptScore W94748627C2779682216 @default.
- W94748627 hasConceptScore W94748627C2779707156 @default.
- W94748627 hasConceptScore W94748627C29537977 @default.
- W94748627 hasConceptScore W94748627C502942594 @default.
- W94748627 hasConceptScore W94748627C54355233 @default.
- W94748627 hasConceptScore W94748627C55493867 @default.
- W94748627 hasConceptScore W94748627C81885089 @default.
- W94748627 hasConceptScore W94748627C86803240 @default.
- W94748627 hasConceptScore W94748627C98274493 @default.
- W94748627 hasIssue "4C" @default.
- W94748627 hasLocation W947486271 @default.
- W94748627 hasOpenAccess W94748627 @default.
- W94748627 hasPrimaryLocation W947486271 @default.
- W94748627 hasRelatedWork W1531780611 @default.
- W94748627 hasRelatedWork W1575303977 @default.
- W94748627 hasRelatedWork W1802202250 @default.
- W94748627 hasRelatedWork W1971988781 @default.
- W94748627 hasRelatedWork W2006380088 @default.
- W94748627 hasRelatedWork W2037826352 @default.
- W94748627 hasRelatedWork W2042658426 @default.
- W94748627 hasRelatedWork W2058959188 @default.
- W94748627 hasRelatedWork W2522386481 @default.
- W94748627 hasRelatedWork W94748627 @default.
- W94748627 hasVolume "18" @default.
- W94748627 isParatext "false" @default.
- W94748627 isRetracted "false" @default.
- W94748627 magId "94748627" @default.
- W94748627 workType "article" @default.